Silva Saarinen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Silva Saarinen has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Lauri A. Aaltonen
Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland
4 shared publications - Rainer Lehtonen
Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland
3 shared publications - Pia Vahteristo
Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland
2 shared publications Ali Ünal
Division of Haematology-Oncology, Department of Medicine, Faculty of Medicine, Dedeman Hospital, Turkey
1 shared publicationBarbara J. Bain
Department of Haematology, St Mary’s Hospital, Campus of Imperial College, London, UK
1 shared publicationFrancesco D'Amore
Department of Haematology, Aarhus University Hospital, Aarhus, Denmark
1 shared publication
Latest Publications
- 25 February 2015
- Published by Wiley in British Journal of Haematology
- Vol. 170 (3) , 428-431
Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing
- 25 February 2015
- Published by Wiley in British Journal of Haematology
- Vol. 170 (3) , 428-431
Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing
- 26 May 2012
- Published by Springer Nature in Familial Cancer
- Vol. 11 (3) , 525-528
Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer
Tylosis with esophageal cancer (TOC) is a rare familial cancer syndrome inherited in an autosomal-dominant manner and characterized by esophageal cancer susceptibility and hyperkeratotic skin lesions. Two heterozygous missense mutations in the RHBDF2 gene were recently reported to be associated with TOC in three families: a p.Ile186Thr mutation was found in families from the UK and the US and a p.Pro189Leu mutation was detected in a German TOC family. We aimed to validate these novel results in an independent material by screening RHBDF2 in a previously unreported Finnish TOC family. We identified a new missense mutation, p.Asp188Asn, segregating with TOC in the Finnish family, and interestingly the detected mutation alters a codon located between the two previously reported mutation sites. Thus, we confirmed RHBDF2 mutations as the underlying cause of the TOC syndrome and our results suggest that the TOC associated mutations might be specific for this particular site in the RHBDF2 gene. These results enable the genetic counseling and diagnostic mutation screening of the members of TOC families.
- 26 May 2012
- Published by Springer Nature in Familial Cancer
- Vol. 11 (3) , 525-528
Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer
Tylosis with esophageal cancer (TOC) is a rare familial cancer syndrome inherited in an autosomal-dominant manner and characterized by esophageal cancer susceptibility and hyperkeratotic skin lesions. Two heterozygous missense mutations in the RHBDF2 gene were recently reported to be associated with TOC in three families: a p.Ile186Thr mutation was found in families from the UK and the US and a p.Pro189Leu mutation was detected in a German TOC family. We aimed to validate these novel results in an independent material by screening RHBDF2 in a previously unreported Finnish TOC family. We identified a new missense mutation, p.Asp188Asn, segregating with TOC in the Finnish family, and interestingly the detected mutation alters a codon located between the two previously reported mutation sites. Thus, we confirmed RHBDF2 mutations as the underlying cause of the TOC syndrome and our results suggest that the TOC associated mutations might be specific for this particular site in the RHBDF2 gene. These results enable the genetic counseling and diagnostic mutation screening of the members of TOC families.
- Open Access
- 19 March 2012
- Published by Springer Nature in Genome Medicine
- Vol. 4 (3) , 21
Rule-based induction method for haplotype comparison and identification of candidate disease loci
There is a need for methods that are able to identify rare variants that cause low or moderate penetrance disease susceptibility. To answer this need, we introduce a rule-based haplotype comparison method, Haplous, which identifies haplotypes within multiple samples from phased genotype data and compares them within and between sample groups. We demonstrate that Haplous is able to accurately identify haplotypes that are identical by descent, exclude common haplotypes in the studied population and select rare haplotypes from the data. Our analysis of three families with multiple individuals affected by lymphoma identified several interesting haplotypes shared by distantly related patients.
- 19 March 2012
- Published by Springer Nature in Genome Medicine
- Vol. 4 (3) , 21
Open AccessRule-based induction method for haplotype comparison and identification of candidate disease loci
There is a need for methods that are able to identify rare variants that cause low or moderate penetrance disease susceptibility. To answer this need, we introduce a rule-based haplotype comparison method, Haplous, which identifies haplotypes within multiple samples from phased genotype data and compares them within and between sample groups. We demonstrate that Haplous is able to accurately identify haplotypes that are identical by descent, exclude common haplotypes in the studied population and select rare haplotypes from the data. Our analysis of three families with multiple individuals affected by lymphoma identified several interesting haplotypes shared by distantly related patients.
- Open Access
- 22 April 2011
- Published by Wiley in British Journal of Haematology
- Vol. 154 (3) , 413-415
Analysis of KLHDC8B in familial nodular lymphocyte predominant Hodgkin lymphoma
- 22 April 2011
- Published by Wiley in British Journal of Haematology
- Vol. 154 (3) , 413-415
Open AccessAnalysis of KLHDC8B in familial nodular lymphocyte predominant Hodgkin lymphoma